-
Australian climber on record sea-to-summit Everest bid
-
Indian opposition slams Nicobar megaport plan as 'destruction'
-
Pentagon chief to testify on Iran war, peace efforts stall
-
Anxiety, resentment around AI spur violence against tech's figureheads
-
Mercedes-Benz profit slides amid cutthroat Chinese market
-
Hungary's Magyar to push post-Orban EU reset on Brussels visit
-
Going online helps Pakistan's women doctors back to work
-
Wembanyama's Spurs advance in NBA playoffs, 76ers stay alive
-
Tropical forest loss eases after record year: researchers
-
Tigres edges Nashville in CONCACAF Champions Cup first leg
-
New Zealand officials reject statue remembering Japan's sex slaves
-
King Charles, Trump toast ties despite Iran tensions
-
Japan cleaner goes viral with spa-like service for plushies
-
What we learned from cycling's Spring Classics
-
Villa, Forest revive European glory days in semi-final showdown
-
Remarkable, ramshackle Rayo chasing Conference League dream amid chaos
-
Unbeaten records on the line for Inoue-Nakatani superfight in Tokyo
-
Cheaper, cleaner electric trucks overhaul China's logistics
-
Stocks swing, oil edges up with Iran war peace talks stalled
-
Europe climate report signals rising extremes
-
Sexual violence in Sudan triggers mental health crisis: UN
-
The loyal, lonely keepers of Sudan's pyramids
-
'Final mission': NZ name star trio for T20 World Cup defence
-
Embiid-led 76ers beat Boston to avoid NBA playoff exit
-
An experimental cafe run by AI opens in Stockholm
-
Exiting fossil fuels key to energy security: nations at Colombia talks
-
Jerome Powell: Fed chair who stood up to Trump set to finish tenure on top
-
All eyes on Powell with US Fed expected to hold rates steady
-
Pentagon makes deal to expand use of Google AI: reports
-
King Charles urges US-UK reset in speech to Trump
-
France unveils plan to ditch all fossil fuels by 2050
-
World Cup to get cash boost as FIFA unveils red card crackdown
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 29
-
Grande Portage Resources Initiates Full Scale Geochemical Characterization Program and Backfill Testwork for the New Amalga Gold Project
-
Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
-
LIV Golf postpones New Orleans event
-
Luis Enrique predicts more thrills in return leg after PSG beat Bayern in classic
-
AI fakes of accused US press gala gunman flood social media
-
Ex-FBI chief Comey charged with threatening Trump's life in Instagram post
-
PSG edge Bayern in nine-goal Champions League semi-final epic
-
Baptiste ends Sabalenka's Madrid title defence
-
Late-night buzz returns to Cairo as war-fuelled energy curbs ease
-
Crude back above $110 on Strait stalemate as US stocks retreat
-
Germany holds breath as stranded whale 'Timmy' sets off in barge
-
King Charles urges Western unity in speech to US Congress
-
'The White Lotus' drafts Laura Dern after Bonham Carter split
-
Trump to put his picture in US passports
-
'Two kings': praise and a royal crush as Trump hosts Charles
-
US Supreme Court hears Cisco bid to halt Falun Gong suit
-
'Exceptional' Arsenal out to dominate at Atletico: Arteta
Cancer, cardiovascular drugs tipped for Nobel as prize week opens
Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Monday when a week of laureate announcements kicks off, bringing a ray of optimism to a world beset by crises.
Awarded since 1901, the Nobel Prizes honour those who have, in the words of prize creator and scientist Alfred Nobel, "conferred the greatest benefit on humankind", highlighting encouraging advances at a time when the world is witnessing devastating wars in the Middle East and Ukraine and a climate on the brink of collapse.
The Nobel Prize in Medicine is first out, announced on Monday around 11:30 am (0930 GMT) in Stockholm.
Among those seen as possible laureates is Kevan Shokat, an American biologist who figured out how to block the KRAS cancer gene behind a third of cancers, including challenging-to-treat lung, colon and pancreatic tumours.
"These are now being tested for new treatments thanks to his discovery," said Annika Ostman, science reporter at Swedish public radio SR.
Research into how to treat cardiovascular illnesses could also get the nod, with the work of geneticists Jonathan Cohen and Helen Hobbs mentioned.
They identified genes that regulate the metabolism of essential lipids such as cholesterol, which has led to a new class of cholesterol-lowering drugs, David Pendlebury, head of the Clarivate analytics group that identifies Nobel-worthy research, told AFP.
Hobbs won the Breakthrough Prize in Life Sciences in 2016, sharing the honour with Swedish geneticist Svante Paabo, who went on to win the Nobel in 2022.
Pendlebury also spotlighted a trio of neuroscientists who have researched the basal ganglia, a region in the brain important for motivation and reward, and how it regulates our behaviour.
The three are US neuroscientist Ann Graybiel, Okihide Hikosaka of Japan and German-born Wolfram Schultz.
Other potential winners are Davor Solter and Azim Surani for their study of epigenetics, which examines how cells control the activities of genes without changing the DNA.
Last year, the medicine prize went to researchers Katalin Kariko and Drew Weissman for their work on messenger RNA technology that paved the way for groundbreaking Covid-19 vaccines.
- Atomic scale microscope -
For the Nobel Prize in Physics, announced on Tuesday, SR's science experts suggested the honour could go to Swiss physicist Christoph Gerber, a pioneer in the development of the atomic force microscope.
"This is a microscope that gives 3D images on such an incredibly small scale that they sometimes are even atomic resolution," said SR science reporter Camilla Widebeck.
The tool has become indispensable in nanotechnology and nano research, she added.
Clarivate also mentioned Gerber as a possible winner, as well as David Deutsch and Peter Shor for their work on quantum algorithms and quantum computing.
Lars Brostrom at SR meanwhile said he hoped to see American-Jordanian Omar Yaghi win Wednesday's chemistry prize.
Yaghi developed a type of customised porous material known as MOF (Metal-organic framework), now used in commercial products that can, among other things, absorb and decontaminate toxins, act as a catalyst or even absorb water from desert air.
Karl Deisseroth, a US psychiatrist and neurologist, has also been mentioned for the past decade as a possible laureate for developing the field of optogenetics, using light to control cells.
Speculation is also rife for the literature prize, to be announced on Thursday and perhaps the most highly anticipated Nobel after the peace prize.
Several pundits believe Chinese author Can Xue will be the Swedish Academy's choice this year -- and she has the lowest odds on several betting sites.
An avant-garde fiction writer often likened to Kafka, her experimental style flips between utopia and dystopia and transforms the mundane into the surreal.
"I think it will be a woman from a language zone outside Europe," Bjorn Wiman, culture editor at Sweden's newspaper of record, Dagens Nyheter, told AFP.
Others suggest it could go to Australian novelist Gerald Murnane, Britain's Salman Rushdie or Kenya's Ngugi wa Thiong'o.
- Who deserves the Peace Prize? -
The climax of the week comes Friday when the Peace Prize laureate is announced, but experts say predictions are harder than ever this year due to the growing number of crises in the world.
The UN agency for Palestinian refugees UNRWA, the International Court of Justice and Afghan women's rights activist Mahbouba Seraj have been mentioned as possibilities.
Given the existential risks to humanity posed by weapons systems that can operate autonomously without human control, several Nobel-watchers have also cited the Campaign to Stop Killer Robots as a potential laureate.
The economics prize wraps up the 2024 Nobel season on October 14.
It could go to research on the economics of child development, the integration of nature in the economy, or the effects of corruption on economic growth.
T.Ward--AMWN